Amarantus Bioscience Holdings Inc (OTCQB:AMBS)

Data as of Oct 22
 -0.0015 / -1.89%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Amarantus Bioscience Holdings, Inc. is a development stage biotechnology company, which engages in discovering and developing treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. It develops and owns intellectual property and proprietary technology to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.

Contact Information

Amarantus Bioscience Holdings, Inc.
953 Indiana Street
San Francisco California 94107
P:(408) 737-2734
Investor Relations:



Individual stakeholders1.19%
Mutual fund holders--
Other institutional--

Top Executives

Gerald E. CommissiongPresident, Chief Executive Officer & Director
Tiffini ClarkHead-Operations & Regulatory Affairs
Robert Edward FarrellChief Financial officer
John W. CommissiongDirector & Chief Scientific Officer
F. Randall GrimesHead-Sponsored Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.